Business Standard

UK's revised dosage interval based on their pandemic situation: V K Paul

Single dose of Covishield reduces infection risk by 60-85 %, shows real life data from UK, says the Niti Aayog member while justifying the interval of two Covishield doses to 12-16 weeks

Covishield coronavirus vaccine | Photo: PTI
Premium

Photo: PTI

Ruchika Chitravanshi New Delhi
Government on Saturday said that it would find out the basis of the decision taken by the UK to keep the coronavirus vaccine dose interval at eight weeks while stressing that the UK's decision is based on their pandemic situation and epidemiology. 

“We have taken our decision based on our risks. Things have changed in the UK as well. It is a dynamic situation and we are driven by science. If the science changes tomorrow we will move forward accordingly,” said V K Paul, member-health Niti Aayog. 

UK Prime Minister Boris Johnson said on Friday that the gap between the first and

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in